QURE

UNIQURE NV

QURE·N90064101·US·Common Stock·Healthcare - Biotechnology-13D/G

QURE (UNIQURE NV) is held by 102 institutional investors as of Q1 2026. Largest holders: Avoro Capital Advisors LLC ($97.4M), Aberdeen Group plc ($86.8M), TWO SIGMA INVESTMENTS, LP ($43.8M). Net institutional sentiment: Mixed.

102
Holders
Avg rating(17 Elite)
$685.9M
Total Value
45% (114)
Fund Consensus
45 buying - 56 selling
QURESmart Money Verdict
View all
Held by 102 funds
17 elite
Who's Trading
InsiderKCKapusta Matthew CSell $233KJun 18, 2026
InsiderKCKapusta Matthew CSell $1.9MJun 18, 2026
InsiderKCKapusta Matthew CSell $1.0MJun 17, 2026
InsiderKCKapusta Matthew CSell $263KJun 17, 2026
InsiderKCKapusta Matthew CSell $1.5MJun 17, 2026
InsiderKCKapusta Matthew CSell $2.5MJun 17, 2026
InsiderKCKapusta Matthew CSell $1.5MJun 17, 2026
InsiderKCKapusta Matthew CSell $564KJun 17, 2026
ActivistRTW Investments, LPRTW Investments, LP4.1%May 15, 2026
ActivistSTATE STREET CORPORATIONSTATE STREET CORPORATION3.6%May 12, 2026
13F: Insider & Congress:
Fund
Action
Shares
Value
Weight
Est. P&L
Conviction
Decreased
6M(-3.1%)$97.4M1.0%+78.61%
0
Increased
5.3M(+44.3%)$86.8M0.1%+233.06%
48
Increased
2.7M(+84.4%)$43.8M0.0%+272.98%
45
Decreased
2.6M(-30.3%)$42.3M0.4%+215.33%
0
Decreased
2.8M(-3.3%)$41.8M0.0%+111.83%
0
Decreased
2.3M(-30.0%)$37M0.0%+86.67%
0
Decreased
1.7M(-72.1%)$28.5M0.0%-15.05%
0
Decreased
1.7M(-12.2%)$28.3M0.0%+99.86%
0
Increased
1.3M(+8.2%)$20.7M0.0%+49.59%
31
Decreased
1.2M(-10.0%)$20.2M0.0%-5.46%
0
Decreased
1M(-17.7%)$16.4M0.0%+49.06%
0
Increased
964,290(+610.9%)$15.8M0.0%+340.38%
45
Increased
816,893(+6.3%)$13.4M0.0%+86.11%
30
Increased
804,610(+3.7%)$13.2M0.0%+43.84%
29
Decreased
792,756(-1.4%)$13M0.0%+80.39%
0
Increased
697,640(+5.4%)$11.4M0.1%+85.17%
35
New
694,721$11.4M0.0%+372.09%
39
New
635,995$10.4M0.0%+372.09%
38
Increased
531,885(+187.9%)$8.7M0.0%+206.31%
44
Decreased
487,838(-0.7%)$8M0.0%+111.51%
0

Showing 1-20 of 114

1 / 6

Other Healthcare stocks held by institutions

Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used